Intermediate for Idelalisib. Idelalisib (trade name Zydelig) is a phosphoinositide 3-kinase inhibitor for the treatment of certain hematological malignancies. Idelalisib has been approved by the U.S Food and Drug Administration on July 23, 2014.


Product Name:                  2-Fluoro-6-nitro-N-phenylbenzamide

Synonyms:                         N/A

CAS Number:                     870281-83-7

Molecular Weight:            260.2241

Molecular Formula:          C13H9FN2O3

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               O=C(c1c(F)cccc1[N+](=O)[O-])Nc1ccccc1


  • $207.00
  • Ex Tax: $207.00

Available Options